About us
D-Sight is a clinical-stage spin-off from the Vall d'Hebron Research Institute (VHIR) developing novel neuroprotective eye drops to prevent vision loss in retinal diseases. Founded by experts in retinal research and clinical translation, the company is advancing a new paradigm based on early, non-invasive intervention.
Our lead program focuses on an innovative topical therapy designed to prevent and treat diabetic retinopathy at its earliest stages, where preserving vision is still possible.
Mission
D-Sight’s mission is to protect vision by advancing first-in-class neuroprotective therapies that intervene early in retinal diseases, shifting care from late-stage management to prevention.
Vision
D-Sight is committed to promoting longevity with a sustained sense of well-being, improving health and aging‐related outcomes worldwide. We aim to provide medical solutions for the growing global health burden due to chronic diseases, such as diabetes.
Changing the way you age